Terms of Use

Effective as of: May 13, 2026 | Version 2.0

1. Acceptance of Terms

These Terms of Use (“Terms”) govern your access to and use of (a) the public website located at mykare.ai, including any related pages, content, and online forms (the “Website”), and (b) any online interfaces, dashboards, APIs, telephony services, or portals through which you access Mykare AI’s AI-powered healthcare automation platform, KareOS, and the associated AI voice and text agents and managed services (collectively, the “Services”). The Website and Services are provided by Mykare Technologies Inc., operating as Mykare AI (“Mykare”, “Mykare AI”, “we”, “us”, or “our”).

By clicking “I Agree,” signing an order form or master services agreement that incorporates these Terms by reference, accessing the Services with a credential issued by Mykare AI or a Customer, or otherwise using the Services on behalf of an organization, you (a) accept these Terms, (b) represent that you are authorized to accept these Terms on behalf of that organization, and (c) bind that organization to these Terms. Only organizations (such as hospitals, clinics, healthcare groups, and similar healthcare providers) may be Customers of the Services; individual users act solely in their capacity as authorized personnel of such organizations. If you do not agree, do not use the Website or Services.

If Mykare AI and your organization have executed a separate master services agreement, statement of work, order form, data processing addendum, and/or Business Associate Agreement (collectively, an “MSA/BAA”), then that MSA/BAA governs any paid or contracted use of the Services. The order of precedence among the documents is set out in Section 22.

2. Eligibility and User Accounts

Access to the Services (other than general browsing of the public Website) is available only to Customers and users who have been onboarded and provisioned by Mykare AI or by a Customer as its authorized user. The Services are not available for self-service sign-up or public registration.

You must be of legal age and capacity under applicable law to enter into these Terms on behalf of your organization and, in any event, must be at least the minimum age permitted under the laws of the State of Delaware to form a binding contract. By using the Website or Services, you represent that you meet these eligibility requirements and that all information you provide is accurate and complete.

You are responsible for maintaining the confidentiality of any user IDs, passwords, API keys, or other credentials associated with your account and for all activities that occur under your account. You agree to notify Mykare AI promptly of any actual or suspected unauthorized use of your credentials or any other security incident relating to the Website or Services. Customers are responsible for ensuring that their users are authorized and for all use of the Services by their users.

3. Permitted Use and Restrictions (Acceptable Use Policy)

Subject to these Terms and any applicable MSA/BAA, Mykare AI grants your organization a limited, non-exclusive, non-transferable, revocable right to access and use the Website and, for authorized Customers and their users, the Services, solely for your internal business purposes and in accordance with applicable law.

You and your users may not:

Use the Website or Services for any unlawful, fraudulent, or harmful purpose, or in violation of any applicable law, regulation, or professional obligation, including those relating to the practice of medicine, telemedicine, telehealth, health information, telemarketing, consumer protection, or data protection.
Attempt to gain unauthorized access to any systems, networks, or data, or circumvent or attempt to circumvent any security or access controls.
Copy, modify, reverse engineer, decompile, disassemble, or attempt to derive the source code or underlying ideas of the Services, except to the limited extent permitted by applicable law notwithstanding this restriction.
Use any automated means (such as bots, crawlers, or scrapers) to access the Website or Services, except as expressly authorized in writing by Mykare AI.
Resell, sublicense, lease, white-label, or otherwise provide access to the Services to any third party, except as expressly permitted in an MSA/BAA.
Use the Services, or any input or output of the Services, to develop, train, fine-tune, evaluate, or improve any product, service, or model that competes with the Services or KareOS, or to benchmark the Services for purposes of competitive analysis without our prior written consent.
Use the Services to engage in or facilitate discrimination, harassment, stalking, surveillance, profiling for the purpose of denying healthcare access on protected-class grounds, the development or operation of weapons, or other unlawful, harmful, or abusive activities.
Upload, transmit, or otherwise provide any content that infringes or misappropriates the rights of others, is illegal, defamatory, or harmful, or contains malicious code or security threats.
Configure the AI voice agents to imitate any identifiable real person’s voice, including clinicians, employees, celebrities, or public figures, or to misrepresent the AI agent as a human.
Use the Services or any output of the AI agents to provide clinical diagnosis, treatment, or independent medical advice to patients without appropriate human medical supervision and clinical responsibility.
Use the Services to make automated or AI-generated outbound calls, prerecorded voice calls, autodialed calls, or text messages to individuals without first obtaining and recording any consents required by applicable law (including the TCPA and applicable state laws), and without honoring opt-out and “STOP” requests.

The Website and Services are intended for professional use by hospitals, clinics, healthcare networks, and similar organizations. They do not provide clinical, medical, legal, immigration, or insurance coverage advice, and the outputs of the Services (including outputs of any AI agent) are informational and operational in nature.

You agree not to submit Protected Health Information (“PHI”), Sensitive Personal Information, or other highly sensitive information via general Website forms, marketing email addresses, or other non-designated channels. PHI and Sensitive Personal Information should only be transmitted through secure channels and workflows identified by Mykare AI and governed by an applicable MSA/BAA.

4. Customer Representations and Compliance Obligations

Customer represents, warrants, and covenants that, with respect to its use of the Services:

All clinical, diagnostic, and treatment decisions are made by licensed clinicians independently of the Services, and Customer is solely responsible for any clinical or medical advice provided to patients.
Customer has obtained, and will maintain, all consents, authorizations, and notices required under applicable law from patients, prospective patients, accompanying attendants, and other Data Subjects for (i) the recording of voice calls, including any all-party consent required in California, Florida, Illinois, Maryland, Massachusetts, Montana, Nevada, New Hampshire, Pennsylvania, Washington, and similar jurisdictions; (ii) the placing of outbound calls and text messages, including any prior express written consent required under the TCPA and applicable state telemarketing and autodialer laws; (iii) the processing of biometric identifiers, including under Illinois BIPA, Texas CUBI, and Washington H.B. 1493; and (iv) the processing of PHI and Sensitive Personal Information, including under HIPAA, the GDPR, and the DPDP Act.
Customer maintains, and will scrub against, applicable internal Do Not Call lists, the federal and state Do Not Call registries, the National Wireless Do Not Call List (where applicable), and any patient-specific suppression lists, and will honor patient opt-out requests promptly.
Customer’s use of the Services, including any commercial or financial arrangements involving patient referrals, complies with the federal Anti-Kickback Statute (42 U.S.C. § 1320a-7b), the Stark Law (42 U.S.C. § 1395nn), the False Claims Act, and state analogues, and does not condition payment to Mykare AI on the volume or value of referrals.
Customer’s use of the Services complies with the U.S. Foreign Corrupt Practices Act (“FCPA”), the UK Bribery Act, the Indian Prevention of Corruption Act, and other applicable anti-bribery and anti-corruption laws.
Customer’s patient-facing scripts and configurations preserve required disclosures, including the AI agent disclosure described in our Privacy Policy and any call-recording notice required by applicable law.
Customer will indemnify Mykare AI for any breach of the foregoing representations, as set out in Section 12.

5. Description of the Services; Changes and Availability

Mykare AI provides an AI-powered healthcare automation platform that combines specialized AI voice and text agents with human oversight, governance guardrails, and analytics to support hospital and provider workflows including patient enquiry handling, inbound and outbound sales, guest relations, international patient coordination (including, where requested, support with travel, visa letters, currency, and logistics), and patient feedback. Mykare AI may provide additional tools, dashboards, integrations, or interfaces as part of the Services.

Mykare AI may improve, modify, or discontinue any portion of the Website or Services from time to time, including by adding or removing features, implementing updates, releasing new agents, retraining models, or performing maintenance, provided that such changes are consistent with any applicable commitments in an MSA/BAA. Mykare AI will use commercially reasonable efforts to schedule planned maintenance to minimize disruption but may perform emergency maintenance when needed.

Any specific service levels, uptime commitments, or credits (if applicable) will be set out in the applicable MSA/BAA. For non-contracted users, no service level is offered.

6. Trials, Pilots, Beta Features, and Commercial Terms

Commercial terms, including pricing, volume, usage limits, payment, and invoicing, are governed by the applicable MSA/BAA and order form, and not by these Terms. If your organization purchases or subscribes to the Services, your use is also subject to the MSA/BAA and any applicable order forms or statements of work.

From time to time, Mykare AI may offer access to trial, pilot, preview, or beta features or services. Any such features are provided on a temporary, evaluation, or experimental basis, may change at any time, and may be terminated or withdrawn by Mykare AI in its sole discretion. Trial, pilot, and beta features are provided “as is” and “as available,” without any warranty or commitment to general availability, and Mykare AI retains all rights, title, and interest in and to such features.

7. Data Ownership and Licenses; Training Opt-Out

As between your organization and Mykare AI:

Your organization retains ownership of its data, including hospital and provider information, and any patient, contact, and operational data it or its systems submit to, or that is captured on its behalf through, the Services, subject to any rights granted in an MSA/BAA.
Mykare AI retains ownership of the Website, the Services, KareOS, the AI agents, AI models, workflows, software, documentation, governance frameworks, and all related intellectual property, including any improvements and derivative works.

You grant Mykare AI a non-exclusive, worldwide, royalty-free license to use, host, process, transmit, and display your organization’s data, including PHI and Sensitive Personal Information, solely as necessary to provide, secure, monitor, and support the Services, to fulfill our obligations under the MSA/BAA, and as otherwise permitted by that agreement and applicable law.

Subject to applicable law and the MSA/BAA, Mykare AI may use (i) de-identified data (de-identified consistent with the HIPAA Safe Harbor method (45 C.F.R. § 164.514(b)(2)) or Expert Determination (§ 164.514(b)(1))), (ii) aggregated data, and (iii) non-PHI metadata derived from your use of the Services, for analytics, security, product improvement, model training, and benchmarking, provided that such data does not identify you, your users, or your patients. Customer may opt out of the use of its data for model improvement by notice to support@mykare.ai; the opt-out will apply prospectively.

8. Intellectual Property and Feedback

All content and materials on the Website and in the Services, including text, graphics, logos, icons, images, software, models, agent personas, voices, prompts, and compilations, are owned by Mykare AI or its licensors and are protected by copyright, trademark, and other intellectual property laws. No rights are granted to you except as expressly stated in these Terms or in an applicable MSA/BAA.

If you provide Mykare AI with feedback, comments, or suggestions regarding the Website or Services, you acknowledge that Mykare AI may use such feedback without restriction and without any obligation to you, and you hereby grant Mykare AI a perpetual, irrevocable, worldwide, royalty-free license to use and exploit that feedback for any lawful purpose.

9. HIPAA, GDPR, DPDP, and Data Protection Agreements

For Customers that are Covered Entities or Business Associates under HIPAA, Mykare AI will enter into a Business Associate Agreement (“BAA”) prior to processing PHI. For Customers subject to the GDPR or UK GDPR, Mykare AI will enter into a Data Processing Addendum (“DPA”) incorporating the European Commission’s Standard Contractual Clauses and the UK International Data Transfer Agreement as applicable. For Customers subject to the DPDP Act, Mykare AI will enter into a data processing agreement consistent with the DPDP Act. A template BAA, DPA, and subprocessor list are available at mykare.ai/trust-center or on request from support@mykare.ai.

If there is any conflict between these Terms and an applicable BAA, DPA, or other data protection agreement with respect to the handling of PHI or Personal Information, the BAA, DPA, or other data protection agreement will control.

Customer is responsible for providing all required notices to and obtaining all required consents from Data Subjects (including patients, prospective patients, and accompanying attendants), including for the recording of calls, processing of medical and travel information, biometric identifiers, and outbound communications, as described in Section 4.

10. Disclaimers

TO THE MAXIMUM EXTENT PERMITTED BY LAW, THE WEBSITE AND SERVICES (INCLUDING ANY TRIAL, PILOT, OR BETA FEATURES, ANY OUTPUT OF ANY AI AGENT, AND ANY DATA, INFORMATION, OR CONTENT PROVIDED THROUGH THE SERVICES) ARE PROVIDED “AS IS” AND “AS AVAILABLE,” WITH ALL FAULTS AND WITHOUT WARRANTIES OF ANY KIND, WHETHER EXPRESS, IMPLIED, STATUTORY, OR OTHERWISE, INCLUDING ANY IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, ACCURACY, COMPLETENESS, TITLE, SYSTEM INTEGRATION, AND NON-INFRINGEMENT. MYKARE AI DOES NOT WARRANT THAT THE WEBSITE OR SERVICES WILL BE UNINTERRUPTED, SECURE, ERROR-FREE, OR FREE OF HARMFUL COMPONENTS, OR THAT THEY WILL MEET YOUR REQUIREMENTS OR EXPECTATIONS.

The Website and Services, including any output generated by AI agents or other components, do not constitute clinical, medical, legal, immigration, or insurance coverage advice. AI-generated content can be incomplete, inaccurate, or misleading (commonly called “hallucinations”); you are solely responsible for reviewing and verifying outputs and for any decisions made on the basis of them. The Services have not been evaluated or cleared by the U.S. Food and Drug Administration as a medical device and are not intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease.

Mykare AI does not guarantee any specific clinical outcome, eligibility determination, coverage, visa decision, booking confirmation, payment, or revenue impact from use of the Services.

11. Limitation of Liability

TO THE MAXIMUM EXTENT PERMITTED BY LAW, IN NO EVENT WILL MYKARE AI OR ITS AFFILIATES, LICENSORS, OR SERVICE PROVIDERS BE LIABLE FOR ANY INDIRECT, INCIDENTAL, CONSEQUENTIAL, SPECIAL, EXEMPLARY, OR PUNITIVE DAMAGES, OR FOR ANY LOSS OF PROFITS, REVENUE, DATA, GOODWILL, BUSINESS OPPORTUNITY, OR ANTICIPATED SAVINGS, ARISING OUT OF OR IN CONNECTION WITH THE WEBSITE, SERVICES, OR THESE TERMS, EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.

Subject to the carve-outs below and to any different allocation of risk in an applicable MSA/BAA, Mykare AI’s aggregate liability arising out of or relating to the Website, Services, and these Terms will not exceed the greater of (i) one hundred U.S. dollars (US$100), or (ii) the amounts paid by Customer to Mykare AI under the applicable MSA in the twelve (12) months preceding the event giving rise to the claim.

Notwithstanding the foregoing, the following claims are excluded from the cap and limitations above (“Carve-Outs”): (a) a party’s indemnification obligations under Section 12; (b) breach of confidentiality obligations; (c) breach of HIPAA, the BAA, a DPA, the GDPR, the DPDP Act, or other applicable data protection laws, in each case caused by gross negligence or willful misconduct of the breaching party; (d) infringement or misappropriation of the other party’s intellectual property rights; (e) liability arising from a party’s fraud, gross negligence, or willful misconduct; and (f) any liability that cannot be limited or excluded under applicable law (including, in some jurisdictions, liability for death or personal injury caused by negligence).

Some jurisdictions do not allow certain limitations of liability; in such cases, the above limitations will apply to you to the fullest extent permitted by applicable law.

12. Mutual Indemnification

12.1 Indemnification by Customer

Customer will defend, indemnify, and hold harmless Mykare AI and its affiliates, officers, directors, employees, and agents from and against any third-party claims, damages, losses, liabilities, costs, and expenses (including reasonable attorneys’ fees) arising out of or related to: (a) Customer’s or its users’ violation of these Terms or applicable law, including healthcare, data protection, telemarketing (including the TCPA), biometric, consumer protection, anti-bribery, and Anti-Kickback laws; (b) Customer’s use of the Website or Services in a manner not permitted by these Terms or an applicable MSA/BAA; (c) any clinical, billing, immigration, or operational decisions made by Customer or its personnel using information obtained from the Services; (d) any data, content, or instructions provided by or on behalf of Customer that infringe or misappropriate any rights of a third party or violate applicable law, including the absence of required notices to or consents from Data Subjects; and (e) Customer’s breach of the representations and obligations in Section 4.

12.2 Indemnification by Mykare AI

Mykare AI will defend, indemnify, and hold harmless Customer and its affiliates, officers, directors, employees, and agents from and against any third-party claims that the Services, as provided by Mykare AI and used by Customer in accordance with these Terms and the applicable MSA/BAA, infringe a third party’s patent, copyright, trademark, or trade secret rights, except to the extent such claim arises from (i) Customer Data or other content provided by Customer; (ii) modifications to the Services not made by Mykare AI; (iii) combination of the Services with products, services, or data not provided by Mykare AI; or (iv) Customer’s use of the Services in violation of these Terms or applicable law. If the Services are or, in Mykare AI’s reasonable opinion, are likely to become the subject of an infringement claim, Mykare AI may, at its option, (A) procure for Customer the right to continue using the Services, (B) replace or modify the Services so that they are non-infringing, or (C) terminate the affected portion of the Services and refund pre-paid, unused fees for the affected period.

12.3 Procedure

The party seeking indemnification will (a) promptly notify the indemnifying party in writing of the claim, (b) give the indemnifying party sole control of the defense and settlement of the claim (provided that no settlement may impose any non-monetary obligation or admission on the indemnified party without its prior written consent, not to be unreasonably withheld), and (c) reasonably cooperate at the indemnifying party’s expense. The indemnified party may participate in the defense with counsel of its own choosing at its own expense.

13. Suspension and Termination

These Terms remain in effect while you access or use the Website or Services.

Mykare AI may suspend or limit access to the Website or Services, in whole or in part, immediately and without prior notice, if Mykare AI reasonably believes that you or your organization (a) pose a security, integrity, or compliance risk to the Services or other users; (b) are engaged in fraudulent or unlawful activity; (c) are using the Services in violation of TCPA, anti-spam, telemarketing, anti-kickback, data protection, or other applicable law; or (d) are otherwise in material breach of these Terms or an applicable MSA/BAA. Mykare AI will give Customer notice of suspension as soon as reasonably practicable.

For material breaches that are capable of cure, Mykare AI will provide written notice and a thirty (30) day cure period before terminating these Terms or the affected Services. The cure period does not apply where (i) immediate suspension is permitted under this Section, (ii) the breach is incapable of cure, or (iii) the MSA/BAA provides for a different cure procedure, in which case that procedure controls.

Termination or suspension of access under these Terms does not by itself terminate any MSA/BAA between Mykare AI and Customer, which will be governed by its own terms. Upon termination of access, any rights granted under these Terms will cease, and you must stop using the Website and Services, except to the extent otherwise permitted under an MSA/BAA.

14. Export Control and Sanctions Compliance

The Website and Services may be subject to United States and other export control and sanctions laws and regulations, including those administered by the U.S. Department of the Treasury’s Office of Foreign Assets Control (“OFAC”), the U.S. Department of Commerce’s Bureau of Industry and Security, and the U.S. Department of State. You represent and warrant that (a) neither you nor your organization, nor any of your or your organization’s directors, officers, owners (direct or indirect), or controlling parties, is located in, organized under the laws of, ordinarily resident in, or owned or controlled by any person or entity in, an embargoed or restricted country or jurisdiction; (b) you and your organization are not identified on any U.S. government restricted-party list (including OFAC’s Specially Designated Nationals and Blocked Persons List, the Sectoral Sanctions Identifications List, the Entity List, or the Denied Persons List), or on any equivalent list maintained by another competent authority; and (c) you will not use the Website or Services in any manner that would cause Mykare AI to be in violation of applicable export control or sanctions laws.

15. Anti-Bribery and Healthcare Fraud Compliance

Each party represents and warrants that, in connection with these Terms and the Services, it will comply with, and will cause its personnel and agents to comply with, applicable anti-bribery and anti-corruption laws, including the U.S. Foreign Corrupt Practices Act, the UK Bribery Act, and (where applicable) the Indian Prevention of Corruption Act. Neither party will, directly or indirectly, offer, promise, give, or authorize the giving of anything of value to any government official, employee of a state-owned enterprise, or private-sector counterparty for the purpose of improperly obtaining or retaining business.

Customer further represents and warrants that its commercial arrangement with Mykare AI, including any pricing or fee structure, is consistent with fair market value and is not based on the volume or value of patient referrals, and that Customer will not use the Services to engage in any arrangement that violates the federal Anti-Kickback Statute (42 U.S.C. § 1320a-7b), the Stark Law (42 U.S.C. § 1395nn), the False Claims Act, or state analogues.

16. Governing Law, Class Action Waiver, and Dispute Resolution

These Terms, and any dispute arising out of or relating to them, the Website, or the Services, are governed by the laws of the State of Delaware, without regard to its conflict-of-laws principles, and by applicable U.S. federal law.

The exclusive jurisdiction and venue for any action or proceeding arising out of or relating to these Terms, the Website, or the Services will be the state and federal courts located in the State of Delaware, and you consent to the personal jurisdiction of such courts. Nothing in this Section limits any rights or obligations set out in an applicable MSA/BAA relating to dispute resolution between Mykare AI and a contracted Customer, including any agreement to arbitrate or to litigate in a different forum.

TO THE FULLEST EXTENT PERMITTED BY LAW, EACH PARTY WAIVES ANY RIGHT TO PARTICIPATE IN A CLASS, COLLECTIVE, OR REPRESENTATIVE ACTION AGAINST THE OTHER PARTY ARISING OUT OF OR RELATING TO THESE TERMS, THE WEBSITE, OR THE SERVICES. DISPUTES WILL BE BROUGHT AND RESOLVED ONLY ON AN INDIVIDUAL BASIS. IF THIS CLASS-ACTION WAIVER IS FOUND UNENFORCEABLE, THE UNENFORCEABLE PORTION WILL BE SEVERED AND THE REMAINDER OF THIS SECTION WILL CONTINUE TO APPLY.

Each party also waives, to the fullest extent permitted by law, any right to a trial by jury in any action arising out of or relating to these Terms.

17. Equitable Relief

You acknowledge that a breach of these Terms relating to confidentiality, intellectual property, the acceptable use restrictions in Section 3, or the customer obligations in Section 4 may cause Mykare AI irreparable harm for which monetary damages would not be an adequate remedy. Accordingly, Mykare AI will be entitled to seek injunctive and other equitable relief in any court of competent jurisdiction without the requirement of posting a bond or showing actual damages, in addition to any other remedies available at law or in equity.

18. Force Majeure

Neither party will be liable for any delay or failure to perform under these Terms (other than the payment of fees) to the extent caused by a force majeure event, including acts of God, fire, flood, earthquake, pandemic or epidemic, war, terrorism, civil unrest, government action, labor dispute, failure or interruption of utility services, internet or telecommunications outages, or attacks by malicious third parties (including denial-of-service attacks), provided that the affected party uses reasonable efforts to mitigate the impact and resumes performance as soon as reasonably practicable.

19. Survival

The following provisions will survive any termination or expiration of these Terms: Sections 4 (Customer Representations), 7 (Data Ownership and Licenses, to the extent of accrued rights), 8 (Intellectual Property and Feedback), 10 (Disclaimers), 11 (Limitation of Liability), 12 (Mutual Indemnification), 14 (Export Control and Sanctions Compliance), 15 (Anti-Bribery and Healthcare Fraud Compliance), 16 (Governing Law, Class Action Waiver, and Dispute Resolution), 17 (Equitable Relief), 19 (Survival), 20 (Notices), 22 (Order of Precedence), and 24 (Miscellaneous), together with any other provisions that by their nature should survive.

20. Notices

Notices to Mykare AI under these Terms must be given in writing and sent to: Mykare Technologies Inc., Attn: Legal, 251 Little Falls Drive, Wilmington, New Castle County, Delaware 19808, USA, with a copy by email to support@mykare.ai. Notices to Customer will be sent to the email address associated with Customer’s account or the address specified in the applicable MSA/BAA. Notices are deemed given (a) upon delivery, if delivered by hand or by overnight courier; (b) three (3) business days after deposit in the U.S. mail (certified or registered, return receipt requested); or (c) upon confirmed transmission, if sent by email.

21. Independent Contractor; No Agency

The parties are independent contractors. Nothing in these Terms creates a partnership, joint venture, agency, franchise, sales representative, or employment relationship between the parties. Neither party has the authority to bind, or assume any obligation on behalf of, the other party.

22. Order of Precedence

In the event of any conflict among the documents that govern Customer’s use of the Services, the following order of precedence applies, from highest to lowest: (1) the BAA (with respect to the handling of PHI); (2) the DPA or other data protection agreement (with respect to the handling of Personal Data subject to GDPR / UK GDPR / DPDP); (3) the MSA and any executed amendments; (4) the applicable order form or statement of work; (5) these Terms; and (6) the Privacy Policy. The Privacy Policy controls solely with respect to the description of Mykare AI’s privacy practices.

23. Changes to These Terms

Mykare AI may update these Terms from time to time. When we do, we will revise the “Effective as of” date at the top of this page. For non-material changes, the changes will be effective when posted. For material changes that adversely affect Customer’s rights or obligations, Mykare AI will provide reasonable advance notice (such as by email, in-product notice, or website notice) of at least thirty (30) days before the effective date. Your continued use of the Website or Services after the effective date constitutes your acceptance of the updated Terms. Updates to an MSA/BAA or other contract will follow the change procedures specified in that agreement.

24. Miscellaneous

These Terms, together with the Privacy Policy and any applicable MSA/BAA between Mykare AI and your organization, constitute the entire agreement between you and Mykare AI with respect to Website use and, for non-contracted users, the Services, and supersede all prior agreements and understandings on the same subject.

If any provision of these Terms is held to be invalid or unenforceable, that provision will be enforced to the maximum extent permissible, and the remaining provisions will remain in full force and effect.

You may not assign or transfer these Terms, by operation of law or otherwise, without Mykare AI’s prior written consent, and any attempted assignment in violation of this restriction is void. Mykare AI may freely assign these Terms in connection with a merger, acquisition, corporate reorganization, financing, or sale of all or substantially all of its assets.

No failure or delay by Mykare AI in exercising any right under these Terms will constitute a waiver of that right. Any waiver must be in writing and signed by Mykare AI. The headings used in these Terms are for convenience only and do not affect interpretation. The words “include,” “including,” and similar expressions are not words of limitation.

25. Contact Us

For any questions regarding these Terms, please contact us at:

Mykare Technologies Inc. (operating as Mykare AI)
Attn: Legal
251 Little Falls Drive
Wilmington, New Castle County
Delaware 19808, USA

Email: support@mykare.ai